Notice to Convene Annual General Meeting 2025
10 Mar 2025 //
ACCESSWIRE
AbbVie &Gubra Announce License Agreement to Develop an Amylin Analog
03 Mar 2025 //
PRESS RELEASE
Gubra reveals early data for once-weekly obesity asset
13 Nov 2024 //
FIERCE BIOTECH
Boehringer and Gubra announce clinical development of first-in-class Treatment
01 Jul 2024 //
PRESS RELEASE